Dexilant Capsule, Delayed Release
Pricing Report NDC 64764-171-30

Current NADAC: $9.85145 per EA · Effective Aug 19, 2026 · Est. package price $295.54 (30 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Dexilant (NDC 64764-171-30) is $9.85145 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Takeda Pharmaceuticals America, Inc., this medication is distributed in a 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.85145
Per EA

Effective Date
Aug 19, 2026
Billable Units
30 EA
Estimated Package Price
$295.54
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $3.96641 (Effective: Aug 19, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $5.38331 to $9.87669 per EA. Over this 12 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.3833 - $9.8767
Market Volatility
83.47% Variance
Latest Trend
0.09%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $9.85145 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $9.84257 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $9.84336 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $9.83613 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $9.83407 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $9.84029 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $9.84755 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $9.85290 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $9.85153 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $9.84777 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $9.84433 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $9.84676 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026